dRx series: deprescribing cholinesterase inhibitors in older people


There are many factors to take into consideration when deprescribing cholinesterase inhibitors say Amanda Quek and Dr Amy Page  Deprescribing is defined as a person-centred process of medication withdrawal intended to achieve improved health outcomes through discontinuation of one or more medications that are either potentially harmful or no longer required. The Clinical Practice Guideline

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Scope offers solution to rising healthcare costs: Guild
Next 'We need to speak up before these models become the norm'